Kewaunee Scientific Corporation
KEQU
Positions held
Your positionsKEQU isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $97.92M | Enterprise value | $147.36M | Trailing P/E | 12.25 | Forward P/E | 15.66 |
| PEG | — | Price / book | 1.31 | Beta | 0.76 | Dividend yield | 0.00% |
| Revenue growth | -6.7% | Earnings growth | -44.2% | Gross margin | 28.6% | Operating margin | 4.8% |
| Profit margin | 3.0% | ROE | 12.5% | ROA | 5.1% | Debt / equity | 0.72 |
| Current ratio | 2.20 | Free cash flow | $9.24M | Analyst recommendation | none | Mean target | — |
| 52w high | $46.57 | 52w low | $32.00 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | |
|---|---|---|---|---|---|
| Revenue | $66.3M | $71.4M | $69.4M | $70.1M | $71.1M |
| Op margin | 4.8% | 7.3% | 3.7% | 5.9% | 6.8% |
| Net income | $1.7M | $3.4M | $0.7M | $2.4M | $3.1M |
| Gross margin | 29.6% | 29.8% | 26.7% | 28.1% | 29.4% |
| Gross profit | $19.6M | $21.2M | $18.5M | $19.7M | $20.9M |
| Operating income | $3.2M | $5.2M | $2.6M | $4.1M | $4.8M |
- Revenue -7% vs prior quarter ($66M vs $71M).
- Gross margin 29.6% (was 29.8% prior quarter).
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $282M | $240M | $204M | $219M |
| Op margin | 5.9% | 7.4% | 9.0% | 2.4% |
| Net income | $9.6M | $11.4M | $18.8M | $0.7M |
| Gross margin | 28.5% | 28.6% | 25.5% | 16.2% |
| Gross profit | $80.4M | $68.9M | $52.1M | $35.6M |
| Operating income | $16.7M | $17.8M | $18.3M | $5.4M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-10 · Kewaunee Q1 Earnings Fall Y/Y Despite International Strength
2026-09-09 · Kewaunee Scientific Fiscal Q1 Earnings, Sales Decrease
2026-09-09 · Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027
2026-08-29 · Kewaunee Scientific Posts Record $282M Revenue, Maps Fiscal 2027 Growth Investments
2026-08-25 · Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
2026-07-22 · The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific
2026-07-21 · Top Research Reports for Eli Lilly, Costco & Morgan Stanley
Price (daily)
Full chart · RSI · MACD · patterns